Loss of FH activity in HLRCC tumours causes accumulation of the Krebs cycle intermediate fumarate to high levels, which may act as an oncometabolite through various, but not necessarily mutually exclusive, mechanisms. This evidence concerns the gene FH and hereditary leiomyomatosis and renal cell cancer.